Loading…
Elevance Health, Inc. is projected to rise to $455.93 by 2027, a +16% move from its current price of $391.47. ELV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $386.09 | $391.67 | $397.33 | +0.05% |
| May 30 | $384.00 | $391.87 | $399.90 | +0.10% |
| May 31 | $382.45 | $392.07 | $401.93 | +0.15% |
| Jun 1 | $381.18 | $392.27 | $403.69 | +0.21% |
| Jun 2 | $380.09 | $392.48 | $405.27 | +0.26% |
| Jun 3 | $379.12 | $392.68 | $406.72 | +0.31% |
| Jun 4 | $378.25 | $392.88 | $408.07 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $378.25 | $392.88 | $408.07 | +0.36% |
| Week 2 | $373.69 | $394.29 | $416.03 | +0.72% |
| Week 3 | $370.54 | $395.71 | $422.59 | +1.08% |
| Week 4 | $368.11 | $397.14 | $428.45 | +1.45% |
| Week 5 | $366.14 | $398.56 | $433.86 | +1.81% |
| Week 6 | $364.50 | $400.00 | $438.96 | +2.18% |
| Week 7 | $363.09 | $401.44 | $443.83 | +2.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands.
The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. It was incorporated in 2001 and is based in Indianapolis, Indiana.
ELV is a health benefits company with four operating segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The stock trades with a current price of $394.69 and a market cap of $85.71B, ranking 189 by market value. The current price sits near a multi-year forecasted path that features a defined 2026 range and a neutral short-term stance.
A major floor 29.2% below — a decisive break under it would weaken the trend.
The nearest floor, 20.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.8% away) — a breakout level to watch.
A major ceiling 17.4% above — clearing it would confirm fresh momentum.
Key ELV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $392.01 | Sell | $391.84 | Sell |
| MA 10 | $394.54 | Sell | $390.54 | Buy |
| MA 20 | $385.64 | Buy | $380.98 | Buy |
| MA 50 | $340.91 | Buy | $356.87 | Buy |
| MA 100 | $338.86 | Buy | $344.67 | Buy |
| MA 200 | $333.70 | Buy | $346.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.17 | Neutral |
| Stoch RSI (14) | 9.22 | Buy |
| CCI (20) | 40.20 | Neutral |
| Williams %R (14) | -36.80 | Info |
| MACD (12,26,9) | -2.39 | Sell |
| ROC (12) | 3.54 | Buy |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 63.20 | Neutral |
| TRIX (15) | 0.74 | Buy |
| Awesome (5,34) | 30.06 | Buy |
| Ultimate (7,14,28) | 55.80 | Neutral |
| Momentum (10) | -1.83 | Sell |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 389.51 | Buy |
| ADX (14) | 40.93 | Buy |
| ATR (14) | 5.23 | Info |
Technically, the 30-day picture is bullish sentiment with RSI(14) at 70, and key moving averages at SMA50 = $337.00 and SMA200 = $332.69. Immediate support is identified at $311.18 and resistance at $402.27. The 30-day price range runs from $358.33 to $434.74, with annualized volatility around 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $280.74 | $391.47 | $518.48 | 0% | Neutral | |
| $372.46 | $455.93 | $584.18 | +16% | Neutral | |
| $408.99 | $509.78 | $670.24 | +30% | Bullish | |
| $457.18 | $578.48 | $776.39 | +48% | Bullish | |
| $495.21 | $634.95 | $867.27 | +62% | Bullish | |
| $601.69 | $780.79 | $1,083.08 | +99% | Bullish | |
| $684.67 | $898.42 | $1,263.78 | +130% | Bullish | |
| $693.21 | $919.14 | $1,309.49 | +135% | Bullish | |
| $749.95 | $1,004.19 | $1,447.60 | +157% | Bullish | |
| $778.04 | $1,051.62 | $1,532.71 | +169% | Bullish | |
| $1,241.46 | $1,749.82 | $2,671.82 | +347% | Bullish | |
| $2,034.93 | $3,075.62 | $5,032.55 | +686% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $280.74 | $391.47 | $457.92 | +0.00% |
| June 2026 | $338.81 | $395.24 | $470.01 | +0.96% |
| July 2026 | $349.64 | $410.23 | $492.45 | +3.79% |
| August 2026 | $355.58 | $419.08 | $506.74 | +2.16% |
| September 2026 | $350.86 | $415.05 | $504.84 | -0.96% |
| October 2026 | $350.94 | $416.56 | $509.41 | +0.36% |
| November 2026 | $356.05 | $423.89 | $520.82 | +1.76% |
| December 2026 | $351.87 | $420.11 | $518.48 | -0.89% |
Click any year to see its month-by-month ELV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Elevance Health, Inc.'s 2026 outlook centres on $391.47, within a $280.74 to $518.48 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ELV could reach as high as $584.18, with a base case around $455.93 and support toward $372.46 — roughly +16% from $391.47. A consolidation phase looks the most probable path here.
Expect ELV to range from $408.99 to $670.24 through 2028. The $509.78 average target implies a +30% move from current prices. That is up +12% on the projected 2027 average. Momentum favours further upside here.
The ELV price prediction for 2029 points to an average of $578.48 (low $457.18, high $776.39) — a potential gain of +48% on today's $391.47. Buyers look set to stay in control over this stretch.
In 2030, ELV is projected to trade between $495.21 and $867.27, averaging $634.95 — a potential gain of +62% from today's $391.47. That is up +10% on the projected 2029 average. Momentum favours further upside here.
Elevance Health, Inc.'s 2031 outlook centres on $780.79, within a $601.69 to $1,083.08 range. That is up +23% on the projected 2030 average. That marks a +99% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ELV could reach as high as $1,263.78, with a base case around $898.42 and support toward $684.67 — roughly +130% from $391.47. Momentum favours further upside here.
Expect ELV to range from $693.21 to $1,309.49 through 2033. The $919.14 average target implies a +135% move from current prices. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ELV price prediction for 2034 points to an average of $1,004.19 (low $749.95, high $1,447.60) — a potential gain of +157% on today's $391.47. Momentum favours further upside here.
In 2035, ELV is projected to trade between $778.04 and $1,532.71, averaging $1,051.62 — a potential gain of +169% from today's $391.47. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Elevance Health, Inc.'s 2040 outlook centres on $1,749.82, within a $1,241.46 to $2,671.82 range. That is up +66% on the projected 2035 average. That marks a +347% change versus current levels. Momentum favours further upside here.
By 2050, ELV could reach as high as $5,032.55, with a base case around $3,075.62 and support toward $2,034.93 — roughly +686% from $391.47. Buyers look set to stay in control over this stretch.
Investing $1,000 in ELV today (≈ 2.554474 ELV) could be worth
$7,856.6
+$6,856.6 (+686%) by 2050 · US Dollar
Based on the average projected ELV price of $3,075.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELVwould be worth at today's price.
$1,000 invested in ELV on May 27, 2025 (≈ 2.659716 ELV) would be worth
$1,041.2
+$41.2 (+4.1%) today · 1.04× · US Dollar
Based on a ELV entry price of $375.98 vs. today's $391.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $396.21 | $988.04 | -1.2% |
| 1 month ago | $356.13 | $1,099.23 | +9.9% |
| 3 months ago | $323.05 | $1,211.79 | +21.2% |
| 6 months ago | $338.26 | $1,157.3 | +15.7% |
| 1 year ago | $375.98 | $1,041.2 | +4.1% |
| All time (5.0y) ago | $394.22 | $993.02 | -0.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELV forecast.
Our base-case forecast reaches $780.00 around 2031.
Implied market cap at $780.00: $169.39B
The year-by-year forecast shows substantial upside beyond 2026. For 2026 the avg is $394.69 with a min of $280.74 and a max of $523.51 (ROI 0). From 2027 onward, the model projects rising averages and positive ROI: 2027 avg $467.12 (ROI 18.4%), 2028 avg $525.25 (ROI 33.1%), 2029 avg $595.83 (ROI 51%), 2030 avg $664.22 (ROI 68.3%), 2031 avg $819.47 (ROI 107.6%), 2032 avg $940.12 (ROI 138.2%), 2033 avg $967.89 (ROI 145.2%), 2034 avg $1,060.32 (ROI 168.7%), 2035 avg $1,111.69 (ROI 181.7%).
The forecast accelerates further: 2040 avg $1,878.10 (ROI 375.8%), 2050 avg $3,319.95 (ROI 741.1%). These figures reflect bullish momentum across the long horizon, though they remain estimates.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $664.22 with a min of $517.95 and a max of $907.44; ROI is 68.3% and sentiment is BULLISH.
The year-by-year forecast shows rising averages from 2027 onward with increasing ROI, including 2027 at 18.4%, 2028 at 33.1%, 2029 at 51%, and 2030 at 68.3%.
Yes. The forecast max values exceed $1,000 starting in 2031 ($1,136.97) and continue higher in subsequent years (2032 max $1,322.67; 2033 max $1,379.17; 2034 max $1,528.75; 2035 max $1,620.50).
Current price is $394.69 and market cap is $85.71B. The rank is 189.
Bullish sentiment with RSI(14) at 70. SMA50 is $337.00 and SMA200 is $332.69. The 30-day range is $358.33 to $434.74, with support at $311.18 and resistance at $402.27; annualized volatility is 30%.
Elevance Health, Inc. Community Discussion
0Share your Elevance Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.